REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Reg- Pharm, S.R.O. (Czech Republic)

Main Activities: Wholesale Trade
Full name: Reg- Pharm, S.R.O. Profile Updated: May 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Reg- Pharm, S.R.O. is an enterprise located in Czech Republic, with the main office in Prague. The enterprise currently operates in the Wholesale Trade sector. It was established on August 06, 1993. Reg- Pharm, S.R.O. currently employs 10 - 19 (2024) people. In 2025, the company reported a net sales revenue increase of 34.05%. Its’ total assets recorded a growth of 43.96%. In 2025, Reg- Pharm, S.R.O.’s net profit margin increased by 2.65%.

Headquarters
Fialkova 2163/45
Prague; The City of Prague; Postal Code: 10600

Contact Details: Purchase the Reg- Pharm, S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Reg- Pharm, S.R.O. report to view the information.
Registered Capital:
Purchase the Reg- Pharm, S.R.O. report to view the information.
Financial Auditors:
Purchase the Reg- Pharm, S.R.O. report to view the information.
Incorporation Date:
August 06, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Reg- Pharm, S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
34.05%▲
Total Operating Revenue
34.81%▲
Operating Profit
48.31%▲
EBITDA
44.95%▲
Net Profit/Loss for the Period
52.39%▲
Total Assets
43.96%▲
Total Equity
24.5%▲
Operating Profit Margin
2.66%▲
Net Profit Margin
2.65%▲
Return on Equity (ROE)
14.32%▲
Quick Ratio
-0.32%▼
Cash Ratio
0.17%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo